SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-12-046402
Filing Date
2012-11-09
Accepted
2012-11-09 13:17:07
Documents
9
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 BIOSPECIFICS TECHNOLOGIES CORP 10-Q 9-30-2012 form10q.htm 10-Q 580758
2 EXHIBIT 31 ex31.htm EX-31 17527
3 EXHIBIT 32 ex32.htm EX-32 7701
  Complete submission text file 0001140361-12-046402.txt   3196202

Data Files

Seq Description Document Type Size
4 INSTANCE DOCUMENT bstc-20120930.xml EX-101.INS 343643
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bstc-20120930.xsd EX-101.SCH 24261
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bstc-20120930_cal.xml EX-101.CAL 37432
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bstc-20120930_def.xml EX-101.DEF 59734
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bstc-20120930_lab.xml EX-101.LAB 332438
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bstc-20120930_pre.xml EX-101.PRE 194900
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34236 | Film No.: 121192736
SIC: 2834 Pharmaceutical Preparations